Rhythm Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Name: Rhythm Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Rhythm Pharmaceuticals Inc.
Rating: 1.50825
Author: Trendlyne DVM scores

about

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

97.92 -1.94 (-1.94%)

113.33% Gain from 52W Low

673.1K

XNAS Volume

XNAS 12 Nov, 2025 4:18 PM (EST)

Board Meeting

The board meeting for Rhythm Pharmaceuticals Inc. is scheduled for today, for the purpose of Guggenheim Second Annual Healthcare Innovation Conference See details